d‐mannosuria levels measured 1 h after d‐mannose intake can select out favorable responders: A pilot study
Sign Up to like & getrecommendations! Published in 2022 at "Neurourology and Urodynamics"
DOI: 10.1002/nau.25059
Abstract: d‐mannose is used as preventive measure against recurrent urinary tract infections (RUTIs). We studied d‐mannosuria after a challenge test to identify favorable responders that could be targeted for long‐term preventive therapy. read more here.
Keywords: mannosuria levels; mannose intake; measured mannose; levels measured ... See more keywords
Comment on “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Pharmacokinetics"
DOI: 10.1007/s40262-020-00950-7
Abstract: After reading the review article by Wijnsma et al. [1] with great interest, we would like to comment on the utility of eculizumab dose monitoring in pregnancy. While Wijnsma et al. describe a strategy for… read more here.
Keywords: comment; comment pharmacology; pharmacology; eculizumab ... See more keywords
Relationship Between Estradiol Levels Measured on the Initiation Day of GnRH Antagonist Treatment and Pregnancy Outcomes in Patients Receiving the Antagonist Protocol
Sign Up to like & getrecommendations! Published in 2025 at "Medicina"
DOI: 10.3390/medicina61040741
Abstract: Background and Objectives: The aim of this study is to evaluate the relationship between serum estradiol (E2) levels measured on the day of antagonist administration and live birth rates (LBRs) in women undergoing IVF-ET with… read more here.
Keywords: antagonist; serum; levels measured; antagonist protocol ... See more keywords